1177 related articles for article (PubMed ID: 19001531)
1. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention.
Hoffmann W; Herzog B; Mühlig S; Kayser H; Fabian R; Thomsen M; Cramer M; Fiss T; Gresselmeyer D; Janhsen K
Ann Pharmacother; 2008 Dec; 42(12):1804-13. PubMed ID: 19001531
[TBL] [Abstract][Full Text] [Related]
2. Intensive community pharmacy intervention had little impact on triptan consumption: a randomized controlled trial.
Søndergaard J; Foged A; Kragstrup J; Gaist D; Gram LF; Sindrup SH; Muckadell HU; Larsen BO; Herborg H; Andersen M
Scand J Prim Health Care; 2006 Mar; 24(1):16-21. PubMed ID: 16464810
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of biofeedback in the treatment of migraine and tension type headaches.
Mullally WJ; Hall K; Goldstein R
Pain Physician; 2009; 12(6):1005-11. PubMed ID: 19935987
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of patients receiving a pharmaceutical care service in Sweden.
Montgomery AT; Sporrong SK; Tully MP; Lindblad AK
J Clin Pharm Ther; 2008 Dec; 33(6):653-62. PubMed ID: 19138243
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of a community pharmacy-based rural asthma management service.
Saini B; Filipovska J; Bosnic-Anticevich S; Taylor S; Krass I; Armour C
Aust J Rural Health; 2008 Apr; 16(2):100-8. PubMed ID: 18318852
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
[TBL] [Abstract][Full Text] [Related]
7. Improving outcomes after myocardial infarction: a randomized controlled trial evaluating effects of a telephone follow-up intervention.
Hanssen TA; Nordrehaug JE; Eide GE; Hanestad BR
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):429-37. PubMed ID: 17568244
[TBL] [Abstract][Full Text] [Related]
8. Email medication counseling services provided by Finnish community pharmacies.
Pohjanoksa-Mäntylä MK; Kulovaara H; Bell JS; Enäkoski M; Airaksinen MS
Ann Pharmacother; 2008 Dec; 42(12):1782-90. PubMed ID: 19033478
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical care and health care utilization in an HMO.
Fischer LR; Defor TA; Cooper S; Scott LM; Boonstra DM; Eelkema MA; Goodman MJ
Eff Clin Pract; 2002; 5(2):49-57. PubMed ID: 11990212
[TBL] [Abstract][Full Text] [Related]
10. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Vicente-Herrero T; Burke TA; Laínez MJ
Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
[TBL] [Abstract][Full Text] [Related]
11. The headache management trial: a randomized study of coordinated care.
Matchar DB; Harpole L; Samsa GP; Jurgelski A; Lipton RB; Silberstein SD; Young W; Kori S; Blumenfeld A
Headache; 2008 Oct; 48(9):1294-310. PubMed ID: 18547268
[TBL] [Abstract][Full Text] [Related]
12. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of an intensive multidisciplinary headache treatment program.
Gunreben-Stempfle B; Griessinger N; Lang E; Muehlhans B; Sittl R; Ulrich K
Headache; 2009 Jul; 49(7):990-1000. PubMed ID: 19473281
[TBL] [Abstract][Full Text] [Related]
14. Migraine and chronic daily headache management: a qualitative study of patients' perceptions.
Peters M; Abu-Saad HH; Vydelingum V; Dowson A; Murphy M
Scand J Caring Sci; 2004 Sep; 18(3):294-303. PubMed ID: 15355524
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and medication preferences of individuals with headache presenting to a community pharmacy.
Wenzel RG; Schommer JC; Marks TG
Headache; 2004 Jan; 44(1):90-4. PubMed ID: 14979890
[TBL] [Abstract][Full Text] [Related]
17. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany.
Berger K; Eickhoff C; Schulz M
J Clin Pharm Ther; 2005 Feb; 30(1):45-57. PubMed ID: 15659003
[TBL] [Abstract][Full Text] [Related]
18. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
19. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
[TBL] [Abstract][Full Text] [Related]
20. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
